According to our latest research, the Global Immunopeptidomics Services market size was valued at $245 million in 2024 and is projected to reach $1.12 billion by 2033, expanding at a CAGR of 18.5% during 2024–2033. The primary factor propelling the growth of the immunopeptidomics services market globally is the rapid expansion of precision medicine and immunotherapy, particularly in oncology and infectious disease research. As pharmaceutical and biotechnology companies intensify their focus on personalized therapeutics, the demand for advanced immunopeptidomics services such as MHC ligandome analysis, neoantigen discovery, and custom peptide identification has surged. These services enable detailed characterization of immune-relevant peptides, facilitating the development of targeted therapies and next-generation vaccines, thus driving robust market growth over the forecast period. https://researchintelo.com/report/immunopeptidomics-services-market